Association of Patient Sex With Chemotherapy-Related Toxic Effects: A Retrospective Analysis of the PETACC-3 Trial Conducted by the EORTC Gastrointestinal Group.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 29800044.
- Also identified by DOI 10.1001/jamaoncol.2018.1080 and PMC identifier 6145725.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This secondary analysis of the PETACC-3 trial examines the association of sex with incidence and severity of chemotherapy-related toxic effects in patients with stage II and III colorectal cancer treated with fluorouracil and leucovorin with or without irinotecan hydrochloride.
Medical subject headings
- Drug Therapy
- Drug-Related Side Effects and Adverse Reactions
- Gastrointestinal Neoplasms
- Gender Identity